RNA, 7SL, cytoplasmic 63, pseudogene (RN7SL63P)

RNA, 7SL, cytoplasmic 63, pseudogene (RN7SL63P) is a processed pseudogene derived from the 7SL RNA gene family, specifically representing a truncated and nonfunctional copy of the 7SL RNA, which is the RNA component of the signal recognition particle (SRP). Pseudogenes like RN7SL63P do not encode functional RNA or protein products, commonly displaying truncations and loss of regulatory elements necessary for transcription or translation, and are typically considered non-functional genomic sequences[1][3][4][6]. RN7SL63P is not implicated as a drug target, disease marker, or therapeutic entity, and there is no evidence for its direct physiological or pathological role. Key details and interpretation: - The "pseudogene" designation clearly indicates loss of function compared to the original 7SL RNA gene, meaning it does not have any known biological or pathological function, nor is it considered a molecular target for therapies[1][4][6]. - The 7SL RNA (the functional ancestor) is an essential component of the signal recognition particle (SRP) complex, which is involved in protein targeting to the endoplasmic reticulum, but RN7SL63P itself is structurally incomplete and functionally obsolete[3][6]. - No documented interaction with drugs, disease relevance, or use as a biomarker exists for RN7SL63P[1][3][4]. - The existence of multiple truncated forms of 7SL pseudogenes in the human genome has been well characterized in molecular studies; RN7SL63P is specifically truncated at both the 5’ and 3’ ends and lacks sequence elements required for any functional transcription or translation[3][6]. Summary convention note: RN7SL63P is not a valid molecular target. If you require similar information for the functional 7SL RNA or its direct involvement in the signal recognition particle, that should be referred to as "7SL RNA" (RN7SL1), not the pseudogene variant.

Other names

RN7SL63P7L63 pseudogeneRNA, 7SL, cytoplasmic 63